The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCELLX INC | COMMON STOCK | 03940C100 | 551,777,926 | 6,720,803 | SH | SOLE | 6,720,803 | 0 | 0 | |||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 427,376,736 | 31,424,760 | SH | SOLE | 31,424,760 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 115,338,010 | 4,505,391 | SH | SOLE | 4,505,391 | 0 | 0 | |||
| GALAPAGOS NV | SPON ADR | 36315X101 | 578,747,003 | 16,707,477 | SH | DFND | 1 | 16,707,477 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 40,777,321 | 4,854,443 | SH | SOLE | 4,854,443 | 0 | 0 | |||
| KYVERNA THERAPEUTICS INC | COM | 501976104 | 24,756,714 | 4,126,119 | SH | SOLE | 4,126,119 | 0 | 0 | |||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 7,673,164 | 9,105,451 | SH | SOLE | 9,105,451 | 0 | 0 | |||
| LEAP THERAPEUTICS INC | COM NEW | 52187K200 | 2,414,893 | 5,319,148 | SH | SOLE | 5,319,148 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 42,605,417 | 452,527 | SH | SOLE | 452,527 | 0 | 0 | |||